Bicara Therapeutics Inc. (BCAX) - Latest Market Data

Price & Market Data

Price: $22.38

Daily Change: -$0.54 / 2.41%

Daily Range: $21.82 - $22.94

Market Cap: $1,470,452,480

Daily Volume: 352,289

Performance Metrics

1 Week: -3.37%

1 Month: 1.08%

3 Months: 49.50%

6 Months: 52.87%

1 Year: 57.72%

YTD: 32.98%

About Bicara Therapeutics Inc. (BCAX)

An in-depth look at Bicara Therapeutics Inc. (BCAX). Trading at 22.38, the stock shows a daily change of -$0.54 / 2.41%. Market cap: 1,470,452,480. Examine its 1-week, 3-month, and 1-year performance.

Company Details

Employees: 103

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Selected stocks

Kustom Entertainment, Inc. (KUST)

Ready Capital Corporation (RC)

Alibaba Group Holding Limited (BABA)

Viant Technology Inc. (DSP)